explore -WSS

explore

author：comprehensive 2025-10-02 20:49:45 - browse：9236

A medical insurance document printed with the words "COPAY," "DEDUCTIBLE," "COINSURANCE," "NON-COVERED," next to a pen — coverage from STAT — Adobe

WASHINGTON — Insurers will have to count drug copay coupons toward deductibles and patient spending caps in most cases, after a Biden move in federal court on Tuesday.

Drug companies use copay coupons to help patients cover the cost of their drugs.

Before now, when drug companies helped patients pay their share of drug costs, insurers often didn’t count that assistance toward deductibles and out-of-pocket limits. In insurance jargon, this tactic is called a copay accumulator. Previously, the practice was only allowed when drug companies give coinsurance assistance for brand drugs with generic competition. The Trump administration let insurers use the tactic when cheaper generics were not available.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： FDA's naming rule on biosimilars has undermined competition

WSS

Readout LOUD Podcast: Legal insider trading, booming biotech stocks

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

ALS groups 'won't be played again' by the FDA, drug sponsors

ALS groups 'won't be played again' by the FDA, drug sponsors

Patient advocates debate FDA's accelerated approval process

Biotech companies concerned about China biosecurity crackdown

hotspot

explore

explore

Medicare details structure of new drug price negotiation program

Obesity now affects over 1 billion people worldwide, study finds

23andMe had bad news about my health. I wish a person had delivered it

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Wildfire smoke exposes gaps in outdoor worker protections

A Q&A with Aletha Maybank, AMA’s chief health equity officer

What does generative AI mean for health care? We asked experts

Washington mulls new rules to avert another Change Healthcare

After affirmative action ruling, medical educators look to 'holistic review'

Covid vaccine financial winners and losers, from Pfizer to Novavax

knowledge

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Pfizer highlights cancer drugs it thinks could reignite investor interest

Readout Newsletter: Merck, Vertex, and Viking updates

Why the world’s most expensive drug might be worth the price

Obesity now affects over 1 billion people worldwide, study finds

Readout LOUD podcast: mifepristone case, GLP

knowledge

focus

Wikipedia

Wikipedia